Abstract

1212Gene-based risk stratification for cardiac disorders in LMNA mutation carriers

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.
Benjamin Meder ... Daniel B Holzer
Clinical research in cardiology : official journal of the German Cardiac Society | VOL. 106
Benjamin Meder, et. al.Benjamin Meder ... Daniel B Holzer
30 Aug 2016
Clinical disease presentation and ECG characteristics of LMNA mutation carriers
Päivi Piirilä ... Eeva Reissell
Open Heart | VOL. 4
Päivi Piirilä, et. al.Päivi Piirilä ... Eeva Reissell
01 Jan 2017
Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications
Joost C.M Meijers ... Annemieke Bakker
International Journal of Cardiology | VOL. 168
Joost C.M Meijers, et. al.Joost C.M Meijers ... Annemieke Bakker
14 Oct 2012
Timing of pacemaker and ICD implantation in LMNA mutation carriers
Sini Weckström ... Kjell Nikus
Open Heart | VOL. 8
Sini Weckström, et. al.Sini Weckström ... Kjell Nikus
01 Apr 2021
View more papers

More From: European Heart Journal

Paper Title
Journal
Date
Author
Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
Roberto Scacciavillani
European heart journal | VOL. -
Roberto ScacciavillaniRoberto Scacciavillani
29 May 2024
Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
Simone Savastano ... Roberto Rordorf
European heart journal | VOL. -
Simone Savastano, et. al.Simone Savastano ... Roberto Rordorf
29 May 2024
Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
Mileen R D Van De Kar ... Luuk C Otterspoor
European heart journal | VOL. -
Mileen R D Van De Kar, et. al.Mileen R D Van De Kar ... Luuk C Otterspoor
29 May 2024
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction.
Milton Packer ... Johann Bauersachs
European heart journal | VOL. -
Milton Packer, et. al.Milton Packer ... Johann Bauersachs
28 May 2024
View more papers